Made Scientific & Regenicin Advance NovaDerm | OrganaBio–RxMP Therapeutics Deal

Philip Morris International Expands Ducati Partnership | Alembic Pharmaceuticals Gains on US FDA Nod

Andelyn Biosciences–ENCell Gene Therapy Deal | Cipla Wins US FDA Nod for Generic Ventolin

Lupin Launches Diabetes Drug in US | US FDA Approves Merck & Co. Idvynso

Rusan Pharma Wins PMDA Japan Approval | US FDA Gives Tentative Nod for Generic Ozempic

Asahi Kasei Acquires AiCuris | CMP Pharma Launches New Norliqva

Sana Biotechnology Partners with Mayo Clinic | Rubicon Research Acquires Arinna Lifesciences

Top Pharmaceutical Companies in India 🇮🇳 | Market Leaders & CEO Insights | ChemXpert

Lupin & Inventia Get US FDA Approval for Dapagliflozin

Alembic Pharmaceuticals & Lupin Get US FDA Nod for Dapagliflozin

Neurocrine Biosciences to Acquire Soleno Therapeutics for $2.9B | Trialt–Viedoc Deal

Apollo Leads Birth Asphyxia Training | Molbio Secures CE MDR Certification

Eli Lilly to Acquire Centessa Pharmaceuticals for $6.3B | Biocytogen–Taisho Pharmaceutical Deal

GSK Exdensur Approved in China | US FDA Updates ARS Pharmaceuticals neffy Label

marter API Sourcing Starts Here | Chemxpert Insights | Watch Till the End!

Rocket Pharmaceuticals Wins US FDA Approval | Novartis to Acquire Excellergy Therapeutics

Azacitidine, Quetiapine & More | Belgium Approvals Q3 2025 | Click to Explore!

Belgium Market Authorization Insights | FY Q3 2025 Pharma Trends 🇧🇪

Galderma Gets US FDA Nod for Restylane Contour | MHLW Japan Clears Bayer Eylea

Rhythm Pharmaceuticals Drug Approved by US FDA | Viatris Effexor Approved in Japan

Melius Secures Australia Release License | Akums Introduces Fast-Acting Migraine Drug

Which Countries Lead in Drug Approvals? | ChemXpert Data Insights

Fridge-Free Vaccine Breakthrough by UKHSA | FDA Approves Novartis Cosentyx for Kids

Luxna Biotech & Inabata GuNA Deal | C2N Diagnostics Alzheimer’s Test Partnership

Truemeds Partners with Paresh Rawal | WHO Foundation & Novo Nordisk Initiative

US FDA Grants Orphan Status to Eledon Pharmaceuticals Drug | Chiesi Group–Bespak Partnership

1. Belgium Drug Approval Summary FY Q3 2025 | Pharma Market Insights

Medtronic to Acquire Scientia Vascular for $550M | Anuh Pharma Passes EDQM Audit

Sino Biological ProPure Breakthrough | US FDA Approves Leucovorin for Rare Disorder

AbbVie’s ABBV-295 Shows Positive Phase 1 Data | Acurx Launches New CDI Trial

Epilepsy Foundation & SeizeSense Team Up | GSK–Alfasigma Linerixibat Deal

Cipla Launches Generic Saxenda in US | FDA Approves YUVIWEL for Achondroplasia

Austria FY Q3-2025 Drug Registrations | Top 6 Molecules Breakdown | ChemXpert

Dupixent Wins US FDA Nod for AFRS | Galderma’s New Restylane Syringe Approved

GSK to Acquire 35Pharma for $950M | Volta & Watchmaker Launch Callisto Kit

Austria Q3-2025 Drug Approval Report | Complete Regulatory Snapshot

Alembic Pharma Wins US FDA Nod for Efinaconazole | Indoco Gets Brivaracetam Approval

Lupin Wins EU Approval for Ranibizumab Biosimilar | Dr Reddy’s Abatacept BLA Accepted by US FDA

Zeus Hygia–Patch House Develop Nutraceutical Systems | Guerbet’s Elucirem Gains Indication

Zydus Launches Anyra (Biosimilar Aflibercept) | Hansa Biopharma’s Imlifidase BLA Accepted by FDA

Medica–Axon Merge in UK Diagnostics | Scinai Acquires Recipharm Israel for Global Expansion

FDA Clears LEX VELO System | Zydus Launches PepAir Respiratory Device

Lupin–Spektus Sign Canada Deal for DeslaFlex | UT Teams Win $500K Grant for Neurostimulation Study

GCCL–MICS Partner on Multinational Trials | Thermo Fisher, Datavant Expand RWD Collaboration

Chemxpert: The Trusted B2B Hub for Pharma & Chemicals

Syngene Partners with Johns Hopkins for Drug Discovery | Akums Wins UK MHRA Nod for Rivaroxaban

Richter’s Fylrevy Wins CHMP Nod | AstraZeneca Seals $18.5B Obesity Drug Deal

FDA OKs Vetmedin for Dogs | Lupin–Galenicum Semaglutide Deal